BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15495238)

  • 1. Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study.
    Andersohn F; Bronder E; Klimpel A; Garbe E
    Am J Hematol; 2004 Nov; 77(3):316-8. PubMed ID: 15495238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood dyscrasias induced by psychotropic drugs.
    Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced blood dyscrasia in Kinki district].
    Nakayama S; Yabe H
    Rinsho Ketsueki; 1991 Jul; 32(7):718-20. PubMed ID: 1920833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematologic side effects of drugs.
    Lubran MM
    Ann Clin Lab Sci; 1989; 19(2):114-21. PubMed ID: 2665627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug allergy damage to the blood ].
    Müller U
    Schweiz Med Wochenschr; 1975 Aug; 105(34):1065-72. PubMed ID: 1166294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematologic toxicity of antidepressive agents].
    Galbaud du Fort G
    Encephale; 1988; 14(4):307-18. PubMed ID: 3058454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced blood dyscrasias in Tohoku district].
    Fukuda M
    Rinsho Ketsueki; 1991 Jul; 32(7):725-8. PubMed ID: 1920835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cases of drug-induced blood disorders in Chugoku district].
    Hino N
    Rinsho Ketsueki; 1991 Jul; 32(7):714-7. PubMed ID: 1920832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptics and blood dyscrasias: a cohort study.
    Blackburn SC; Oliart AD; García Rodríguez LA; Pérez Gutthann S
    Pharmacotherapy; 1998; 18(6):1277-83. PubMed ID: 9855327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced blood dyscrasias.
    Eisenhauer LA
    Nurs Clin North Am; 1972 Dec; 7(4):799-808. PubMed ID: 4485732
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
    Garbe E; Andersohn F; Bronder E; Klimpel A; Thomae M; Schrezenmeier H; Hildebrandt M; Späth-Schwalbe E; Grüneisen A; Mayer B; Salama A; Kurtal H
    Br J Haematol; 2011 Sep; 154(5):644-53. PubMed ID: 21749359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced blood dyscrasias.
    Casey TP
    N Z Med J; 1968 Jun; 67(433):599-606. PubMed ID: 4877026
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-associated disease: hematologic dysfunction.
    Vandendries ER; Drews RE
    Crit Care Clin; 2006 Apr; 22(2):347-55, viii. PubMed ID: 16678004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of clinical blood dyscrasia in a cohort of antibiotic users.
    Huerta C; García Rodríguez LA
    Pharmacotherapy; 2002 May; 22(5):630-6. PubMed ID: 12013362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms in drug-induced blood dyscrasias.
    Nydegger U; Miescher PA
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():46-9. PubMed ID: 783213
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs and hematologic toxicity].
    Marcelli A
    Sem Hop; 1977 Feb; 53(8):497-502. PubMed ID: 190699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on the use of intravenous immune globulin for hematologic conditions.
    Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.